Crossmark

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

Crossref DOI link: https://doi.org/10.15252/emmm.201707988

Published Online: 2017-12-15

Published Print: 2018-02

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Trochet, Delphine https://orcid.org/0000-0002-9216-6117
Prudhon, Bernard

Beuvin, Maud

Peccate, Cécile

Lorain, Stéphanie

Julien, Laura

Benkhelifa‐Ziyyat, Sofia

Rabai, Aymen

Mamchaoui, Kamel

Ferry, Arnaud

Laporte, Jocelyn

Guicheney, Pascale https://orcid.org/0000-0002-7663-2050
Vassilopoulos, Stéphane

Bitoun, Marc https://orcid.org/0000-0002-4188-7918
Funding

Funding for this research was provided by:

Institut National de la Santé et de la Recherche Médicale

Université Pierre et Marie Curie

Centre National de la Recherche Scientifique

Agence Nationale de la Recherche (ANR‐14‐CE12‐0009)

Agence Nationale de la Recherche (ANR‐14‐CE12‐0001‐01)

Agence Nationale de la Recherche (ANR‐14‐CE12‐0009)
License Information

Version of Record valid from 2017-12-15
More Information

Publication History

Received: 2017-05-05

Accepted: 2017-11-20

Published: 2017-12-15